KURN — Kuros Biosciences AG Share News
0.000.00%
- CH₣828.53m
- CH₣831.76m
- $146.06m
Brief: Kuros Biosciences' Chief Medical Officer To Retire
Swiss stocks - Factors to watch on Nov 23
Brief: Kuros secures equity financing of up to CHF 30 million
Brief: Kuros Biosciences appoints Joost de Bruijn as CEO
Brief: Kuros Biosciences H1 net loss narrows to CHF 7.0 million
Brief: Kuros receives clearance for MagnetOs Putty for commercialization in US
Swiss stocks - Factors to watch on July 31
Brief: Kuros Biosciences announces full exercise of over-allotment option
Brief: Kuros strengthens equity base with placement of new shares
Swiss stocks - Factors to watch on June 21
Brief: Kuros Biosciences receives CE certification for Neuroseal
Swiss stocks - Factors to watch on June 19
Brief: Kuros Biosciences launches rights and share offering
Brief: Kuros Biosciences proposes election of four new board members
Brief: Kuros FY revenue up at CHF 1.06 million
Brief: Kuros Biosciences appoints Ivan Cohen-Tanugi as CEO
Brief: Kuros Biosciences receives clearance from FDA for MagnetOs
Brief: Kuros Biosciences says achieves ISO certification for surgical sealants
Brief: Kuros Biosciences submits regulatory filing seeking CE certification for neuroseal